Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial

Publisher's Note

The article by Demetri et al, entitled "Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial" (J Clin Oncol 10.1200/JCO.2015.62.4734), was published online September 14, 2015, with a Statistical Analysis Plan missing. This file should have been uploaded as a Data Supplement.

This has been corrected as of September 21, 2015.